Jerrell Shelton, Cryoport chief executive officer, said, “We are delighted that we have this new partnership with OCASA. It is centered around our ‘powered by Cryoport’ strategy and makes all of our solutions available to OCASA. OCASA has a particularly strong presence in certain geographies of interest and has already been providing reliable logistics services to some of our customers on a global basis. With this expanded relationship, we will accelerate sales into these markets and further broaden the awareness of our solutions in the biotechnology and life sciences industries.”
OCASA’s services include export, import/customs clearance, temperature-controlled warehousing, secondary packaging and labeling, distribution, fulfillment, and general cold chain logistics for clinical trial investigational products. It also handles clinical trial samples/test kits, diagnostic specimens, commercial medications/vaccines, medical supplies/kits, controlled products, and dangerous infectious goods.
For more information, go to www.ocasa.com/.
Cryoport provides frozen shipping logistics services to the biotechnology and life science industries. Cryoport Express liquid nitrogen dry vapor shippers are validated to maintain a constant –150° C temperature for a 10-plus-day dynamic shipment duration, and the Cryoportal platform manages the entire shipment process.
For more details, access www.cryoport.com.
